Go Pro
NASDAQ:PETS

PetMed Express Q3 2026 Earnings Report

PetMed Express logo
$1.53 0.00 (0.00%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$1.55 +0.02 (+1.31%)
As of 09/25/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PetMed Express EPS Results

Actual EPS
-$0.50
Consensus EPS
-$0.06
Beat/Miss
Missed by -$0.44
One Year Ago EPS
N/A

PetMed Express Revenue Results

Actual Revenue
$40.66 million
Expected Revenue
$54.04 million
Beat/Miss
Missed by -$13.38 million
YoY Revenue Growth
N/A

PetMed Express Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Wednesday, February 4, 2026
Conference Call Time
6:00PM ET

Upcoming Earnings

PetMed Express' Q2 2027 earnings is estimated for Tuesday, October 13, 2026, based on past reporting schedules

Earnings Documents

PetMed Express Earnings Headlines

PetMeds Appoints Tamar Elkeles As Independent Director
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
PetMed Express adds human capital expert to board
See More PetMed Express Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email.

About PetMed Express

PetMed Express (NASDAQ:PETS), doing business as PetMeds, is a direct-to-consumer pet pharmacy and online retailer. The company sells prescription and nonprescription medications, flea and tick treatments, vitamins and supplements, prescription diets, and other health products for dogs, cats, and other companion animals.

PetMeds offers products through its website and other direct-order channels, providing pet owners with access to medications and supplies that may be recommended or prescribed by veterinarians. Its business model is focused on convenience, home delivery, and recurring purchases for ongoing pet-health needs.

Founded in 1996, PetMed Express is headquartered in Delray Beach, Florida, and primarily serves customers in the United States. The company operates under the PetMeds and 1-800-PetMeds brands and is traded on the Nasdaq under the symbol PETS.

View PetMed Express Profile